CYL Corporation Berhad (KLSE:CYL)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions MYR. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Net Income	1.21	-0.41	-1.57	-0.18	1.35	1.61
Depreciation & Amortization	0.73	3	2.84	2.82	3.08	3.36
Loss (Gain) From Sale of Assets	0	-0.06	-0.04	-0.05	-0.01	-0.04
Asset Writedown & Restructuring Costs	-0	0.47	-	-	0	0.12
Provision & Write-off of Bad Debts	-0	0.01	-0.01	0.01	-0.21	0.19
Other Operating Activities	0.22	1.13	0.35	0.02	0.23	-0.61
Change in Accounts Receivable	-2.59	-1.14	-1.5	3.46	-1.77	-2.22
Change in Inventory	1.7	-1.09	0.91	-0.96	1.38	-2.05
Change in Accounts Payable	-0.42	0.3	0.24	-1.81	-1.45	2.53
Change in Unearned Revenue	-0.1	-0.03	0.18	-	-	-
Change in Other Net Operating Assets	-0	-0	-0	-0.01	0.01	0
Operating Cash Flow	0.73	2.19	1.4	3.31	2.61	2.89
Operating Cash Flow Growth	-84.13%	56.84%	-57.83%	26.69%	-9.50%	-56.32%
Capital Expenditures	-0.5	-2.37	-3.41	-1.12	-1.98	-1.89
Sale of Property, Plant & Equipment	0	0.06	0.04	0.05	0.01	0.04
Sale (Purchase) of Real Estate	-0	-0.63	-	-	-	-
Other Investing Activities	-0	-0.86	-	-	-	-0.59
Investing Cash Flow	-0.5	-3.79	-3.38	-1.07	-1.97	-2.44
Long-Term Debt Repaid	-	-0.05	-	-	-	-
Net Debt Issued (Repaid)	-0.02	-0.05	-	-	-	-
Common Dividends Paid	-0.5	-	-	-	-1	-0.5
Other Financing Activities	-0	-0	-	-	-	-
Financing Cash Flow	-0.52	-0.05	-	-	-1	-0.5
Net Cash Flow	-0.29	-1.65	-1.98	2.25	-0.36	-0.05
Free Cash Flow	0.23	-0.18	-2.02	2.2	0.63	1
Free Cash Flow Growth	-	-	-	247.63%	-36.80%	-82.33%
Free Cash Flow Margin	0.45%	-0.36%	-4.68%	4.87%	1.27%	2.34%
Free Cash Flow Per Share	0.00	-0.00	-0.02	0.02	0.01	0.01
Cash Interest Paid	0	0	-	-	-	-
Cash Income Tax Paid	0.89	0.84	-0.51	0.11	-0.29	0.14
Levered Free Cash Flow	11.27	6.92	6.24	8.04	6.5	8.13
Unlevered Free Cash Flow	11.33	6.96	6.27	8.04	6.5	8.13
Change in Net Working Capital	-2.31	1.47	-1.44	-0.31	1.55	0.54

Updated Dec 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.